In a regulatory filing, InspireMD disclosed that its director Gary Roubin bought 50K shares of common stock on November 30th in a total transaction size of $126.5K. Shares of InspireMD are up 5.7% afterhours at $2.59.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See Insiders’ Hot Stocks on TipRanks >>
Read More on NSPR:
- InspireMD Announces Strategic Agreement with Jacobs Institute to Execute Early Feasibility Study of CGuard EPS for the Treatment of Acute Stroke Patients with Tandem Lesions
- InspireMD announces strategic agreement with Jacobs Institute
- InspireMD reports Q3 EPS (15c) vs (58c) last year
- InspireMD Reports Third Quarter 2023 Financial Results and Provides Business Update
- InspireMD Inc (NSPR) Q3 Earnings Cheat Sheet
